Search results :

Regadenoson

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: C01EB21

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3
Dyspnoea Dyspnoea postmarketing — 10.7% - 29% 1.1% - 2.6% x x x
Headache Headache very common, 17% - 27% x x x
Flushing Flushing very common, 16% - 25% x x x
Chest pain Chest discomfort 13% - 18% x x
Chest pain very common, 7% - 19% x x x
Chest discomfort Chest discomfort 13% - 18% x x
Electrocardiogram ST segment Electrocardiogram ST segment very common x
Abdominal discomfort Gastrointestinal discomfort very common, 15% x
Abdominal discomfort 2% - 5% x x
Electrocardiogram ST segment depression Electrocardiogram ST segment depression 12% - 18% x x
Angina pectoris Angina pectoris common, 12% - 18% x x x
Dizziness Dizziness very common, 7% - 11% x x x
Syncope postmarketing, uncommon x x
Feeling hot Feeling hot 5% - 8% x x
Nausea Nausea postmarketing — 6% x x x
Asthenia Asthenia common x
Atrioventricular block Atrioventricular block common x x x
Block heart postmarketing x
Nodal block x
Cough Cough common x
Dysgeusia Dysgeusia common, 5% - 7% x x x
Hyperhidrosis Hyperhidrosis common x
Hypoaesthesia Hypoaesthesia common x
Pain in extremity Pain in extremity common x
Palpitations Palpitations common x
Paraesthesia Paraesthesia common x
Tachycardia Tachycardia common x
Malaise Malaise common x
Discomfort Malaise common x
Feeling abnormal Malaise common x
Ill-defined disorder Malaise common x
Pain in jaw Pain in jaw common x
Oral discomfort Oral discomfort common x
Throat irritation Throat irritation common x
Musculoskeletal discomfort Musculoskeletal discomfort common x
Arthralgia uncommon x
Myalgia postmarketing x
Hypotension Hypotension postmarketing, common x x
Hypotension symptomatic postmarketing x
Vomiting Vomiting postmarketing, common x x
Throat tightness Throat tightness postmarketing, common x x
Electrocardiogram QT prolonged Electrocardiogram QT corrected interval prolonged postmarketing, common x x
Wheezing Wheezing postmarketing, 0.9% - 3.1% 0.7% - 1.1% x
Abdominal distension Abdominal distension uncommon x
Anxiety Anxiety uncommon x
Arthralgia Arthralgia uncommon x
Cardiac flutter Cardiac flutter uncommon x x
Pallor Pallor uncommon x
Tinnitus Tinnitus uncommon x
Erythema Erythema uncommon x
Atrioventricular block complete Atrioventricular block complete uncommon x
Eye pain Eye pain uncommon x
Injection site pain Injection site pain uncommon x
Tachypnoea Tachypnoea uncommon x
Peripheral coldness Peripheral coldness uncommon x
Pain Generalized aching uncommon x
Pain postmarketing x
Vision blurred Vision blurred uncommon x
Bradycardia Bradycardia uncommon x
Altered state of consciousness Depressed level of consciousness uncommon x
Depressed level of consciousness Depressed level of consciousness uncommon x
Insomnia Insomnia uncommon x
Somnolence Somnolence uncommon x
Atrial fibrillation Atrial fibrillation postmarketing, uncommon x x x
Diarrhoea Diarrhoea postmarketing, uncommon x x
Faecal incontinence Faecal incontinence postmarketing, uncommon x x
Cardiac arrest Cardiac arrest postmarketing, uncommon x x
Hypertension Hypertension postmarketing, uncommon x x
Myocardial infarction Myocardial infarction postmarketing, uncommon x x
Acute coronary syndrome Myocardial infarction postmarketing, uncommon x x
Shock Syncope postmarketing, uncommon x x
Syncope Syncope postmarketing, uncommon x x
Loss of consciousness Syncope postmarketing, uncommon x x
Tremor Tremor postmarketing, uncommon x x
Abdominal pain Abdominal pain postmarketing x
Gastrointestinal pain Abdominal pain postmarketing x
Anaphylactic shock Anaphylactic shock postmarketing x x
Angioedema Angioedema postmarketing x x
Atrial flutter Atrial flutter postmarketing x
Transient ischaemic attack Transient ischaemic attack postmarketing, uncommon x x
Dermatitis Rash postmarketing x x
Rash Rash postmarketing x x
Hypersensitivity Hypersensitivity postmarketing x x
Musculoskeletal pain Musculoskeletal pain postmarketing x
Convulsion Convulsion postmarketing, uncommon x x
Cerebrovascular accident Cerebrovascular accident postmarketing x
Urticaria Urticaria postmarketing x x
Ventricular arrhythmia Ventricular arrhythmia postmarketing x x x
Haemorrhage intracranial Haemorrhage intracranial postmarketing x
Respiratory arrest Respiratory arrest postmarketing x
Myalgia Myalgia postmarketing x
Respiratory distress Respiratory distress postmarketing x
Oxygen saturation decreased Oxygen saturation decreased postmarketing x
Supraventricular tachyarrhythmia Supraventricular tachyarrhythmia postmarketing x
Asthma Asthma x
Mental disorder Mental disorder x
Connective tissue disorder Connective tissue disorder x
Eye disorder Eye disorder x
Gastrointestinal disorder Gastrointestinal disorder x
Cardiac disorder Cardiac disorder x
Immune system disorder Immune system disorder x
Ischaemia Ischaemia x
Chronic obstructive pulmonary disease Chronic obstructive pulmonary disease x
Bronchial hyperreactivity Chronic obstructive pulmonary disease x
Mediastinal disorder Mediastinal disorder x
Nervous system disorder Nervous system disorder x
Angiopathy Angiopathy x
Vasodilation procedure Vasodilation x
Bronchospasm Bronchoconstriction x
Sinus bradycardia Sinus bradycardia x
Atrioventricular block first degree Atrioventricular block first degree x x x
Myocardial ischaemia Myocardial ischaemia x x
Skin disorder Unspecified disorder of skin and subcutaneous tissue x
Atrioventricular block second degree Atrioventricular block second degree x x x
Blood pressure systolic decreased Blood pressure systolic decreased x
Blood pressure diastolic decreased Blood pressure diastolic decreased x
Extrasystoles Dropped beats x
Electrocardiogram PR prolongation Electrocardiogram PR prolongation x x x
Wandering pacemaker Wandering pacemaker x
Renal failure Renal impairment x
Renal impairment Renal impairment x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

REGADENOSON / LEXISCAN

Side effects:20
Source:FDA

REGADENOSON ANHYDROUS

Side effects:56
Source:FDA Structured Product Label

regadenoson / regadenoson

Side effects:83
Source:EMA

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label